Clinical trial
Sodium Stibogluconate and Interferon in Treating Patients With Advanced Solid…
NCT00311558 · The Cleveland Clinic, Other · Terminated
Key facts
| NCT number | NCT00311558 |
|---|---|
| Title | Sodium Stibogluconate and Interferon in Treating Patients With Advanced Solid Tumors, Lymphoma, or Myeloma |
| Official title | Phase I Evaluation of Sodium Stibogluconate in Combination With Interferon α-2b for Solid Tumors, Lymphoma or Myeloma |
| Lead sponsor | The Cleveland Clinic, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Cancer |
| Intervention type | Biological, Drug |
| Interventions | recombinant interferon alfa-2b, sodium stibogluconate, SSG & interferon |
| Enrollment | 18 |
| Start date | Oct 1, 2005 |
| Primary completion | May 1, 2011 |
| Completion | Jan 1, 2012 |
| First posted | Apr 6, 2006 |
| Last update posted | Jan 26, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: